美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Clene Inc Warrant

0.0018

0.0000

成交量：- -

成交額：- -

市值：- -

市盈率：0.00

高：0.0018

開：0.0018

低：0.0018

收：0.0018

52周最高：0.0448

52周最低：0.0013

股本：- -

流通股本：- -

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-3.3279

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Clene Inc Warrant

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.clene.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Clene Inc.於2017年11月13日成立。Clene是一家臨床階段的生物製藥公司，致力於開發神經退行性疾病的獨特療法。Clene發明了一種新型納米技術藥物平台，用於開發新型口服神經治療藥物。Clene還將一種用於抗病毒和抗菌的離子鋅和銀水溶液推向臨床。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/CLNNW/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CLNNW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLNNW\",,,,,undefined,":{"symbol":"CLNNW","market":"US","secType":"STK","nameCN":"Clene Inc Warrant","latestPrice":0.0018,"timestamp":1774371094615,"preClose":0.0018,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":0,"shares":0,"eps":-3.3279,"marketStatus":"停牌","change":0,"latestTime":"03-24 12:51:34 EDT","open":0.0018,"high":0.0018,"low":0.0018,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-3.3279,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1774382400000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.0018,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLNNW\",,,,,undefined,":{"symbol":"CLNNW","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":0.0018,"amplitude":0,"preClose":0.0018,"low":0.0018,"week52Low":0.0013,"pbRate":"--","week52High":0.0448,"institutionHeld":0,"latestPrice":0.0018,"eps":-3.3279,"divideRate":0,"volume":0,"delay":0,"ttmEps":-3.3279,"open":0.0018,"prevYearClose":0.0018,"prevWeekClose":0.0018,"prevMonthClose":0.0018,"prevQuarterClose":0.0018,"fiveDayClose":0.0018,"twentyDayClose":0.0018,"sixtyDayClose":0.0034},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CLNNW\",params:#limit:5,,,undefined,":[{"date":"2026-03-12","symbol":"CLNNW","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1773302400000,"name":null,"time":"盤前","dateTimestamp":1773288000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CLNNW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CLNNW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.clene.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":-0.6087},{"period":"6month","weight":-0.9398},{"period":"1year","weight":-0.9432},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0204},{"period":"1month","weight":-0.0494},{"period":"3month","weight":-0.0474},{"period":"6month","weight":-0.0087},{"period":"1year","weight":0.1621},{"period":"ytd","weight":-0.0389}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Clene Inc.於2017年11月13日成立。Clene是一家臨床階段的生物製藥公司，致力於開發神經退行性疾病的獨特療法。Clene發明了一種新型納米技術藥物平台，用於開發新型口服神經治療藥物。Clene還將一種用於抗病毒和抗菌的離子鋅和銀水溶液推向臨床。","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":0.401649},{"month":2,"riseRate":0.666667,"avgChangeRate":0.33778},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.113957},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.10643},{"month":5,"riseRate":0.285714,"avgChangeRate":0.013229},{"month":6,"riseRate":0.571429,"avgChangeRate":0.604599},{"month":7,"riseRate":0.285714,"avgChangeRate":0.024188},{"month":8,"riseRate":0.285714,"avgChangeRate":0.106371},{"month":9,"riseRate":0.25,"avgChangeRate":0.137384},{"month":10,"riseRate":0.25,"avgChangeRate":-0.2546},{"month":11,"riseRate":0.428571,"avgChangeRate":-0.092071},{"month":12,"riseRate":0.375,"avgChangeRate":0.035835}],"exchange":"NASDAQ","name":"Clene Inc Warrant","nameEN":"Clene Inc Warrant"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CLNNW\",market:\"US\",,,undefined,":null}}